| Literature DB >> 34961280 |
Irina Ielciu1, Gabriela Adriana Filip2, Ilioara Oniga3, Neli-Kinga Olah4,5, Ioana Bâldea2, Diana Olteanu2, Ramona Flavia Burtescu5, Violeta Turcuș6, Alexandra C Sevastre-Berghian2, Daniela Benedec3, Daniela Hanganu3.
Abstract
The present study aimed to compare two polyphenolic-enriched extracts obtained from the Thymus marschallianus Willd. (Lamiaceae) species, harvested from culture (TMCE in doses of 0.66 μg GAE/mL and 0.066 μg GAE/mL) and from spontaneous flora (TMSE in doses of 0.94 μg GAE/mL and 0.094 μg GAE/mL) by assessing their biological effects on human umbilical vein endothelial cells (HUVECs) exposed to normoglycemic (137 mmol/L glucose) and hyperglycemic conditions (200 mmol/L glucose). Extracts were obtained by solid phase extraction (SPE) and analyzed by chromatographical (HPLC-DAD) and spectrophotometrical methods. Their effects on hyperglycemia were evaluated by the quantification of oxidative stress and NF-ĸB, pNF-ĸB, HIF-1α, and γ-H2AX expressions. The HPLC-DAD analysis highlighted significant amounts of rosmarinic acid (ranging between 0.18 and 1.81 mg/g dry extract), luteolin (ranging between 2.04 and 17.71 mg/g dry extract), kaempferol (ranging between 1.85 and 7.39 mg/g dry extract), and apigenin (ranging between 4.97 and 65.67 mg/g dry extract). Exposure to hyperglycemia induced oxidative stress and the activation of NF-ĸ increased the expression of HIF-1α and produced DNA lesions. The polyphenolic-enriched extracts proved a significant reduction of oxidative stress and γ-H2AX formation and improved the expression of HIF-1α, suggesting their protective role on endothelial cells in hyperglycemia. The tested extracts reduced the total NF-ĸB expression and diminished its activation in hyperglycemic conditions. The obtained results bring evidence for the use of the polyphenolic-enriched extracts of T. marschallianus as adjuvants in hyperglycemia.Entities:
Keywords: HIF-1; NF-ĸB; T. marschallianus; oxidative stress; polyphenolic enriched extracts; γ-H2AX
Year: 2021 PMID: 34961280 PMCID: PMC8708594 DOI: 10.3390/plants10122810
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Results obtained for the quantification of TPA, TFC, and TPC by HPLC-DAD * and spectrophotometrical ** methods.
| Sample | TPA (mg CAE/g) * | TFC (mg RE/g) * | TPC (mg GAE/g) ** |
|---|---|---|---|
| TMC | 3.16 ± 0.08 | 2.49 ± 0.05 | 5.72 ± 0.12 |
| TMCE | 3.19 ± 0.02 | 6.78 ± 0.05 | 10.34 ± 0.15 |
| TMS | 3.32 ± 0.01 | 1.45 ± 0.04 | 5.39 ± 0.10 |
| TMSE | 4.02 ± 0.07 | 2.83 ± 0.01 | 7.26 ± 0.11 |
Note: Values represent the mean ± standard deviations of three independent measurements.
Results obtained for the HPLC quantification of polyphenolic compounds.
| Sample | Rosmarinic Acid (mg/g) | Luteolin (mg/g) | Kaempferol (mg/g) | Apigenin (mg/g) |
|---|---|---|---|---|
| TMC | 0.18 ± 0.02 | 2.04 ± 0.10 | 1.85 ± 0.01 | 4.97 ± 0.02 |
| TMCE | 0.31 ± 0.11 | 17.71 ± 0.52 | 7.39 ± 0.02 | 65.67 ± 0.09 |
| TMS | 0.18 ± 0.54 | 4.17 ± 0.11 | 2.75 ± 0.01 | 5.50 ± 0.02 |
| TMSE | 0.24 ± 0.32 | 5.69 ± 0.25 | 5.69 ± 0.02 | 14.63 ± 0.04 |
Note: Values represent the mean ± standard deviations of three independent measurements.
Figure 1HPLC-DAD chromatograms at 254 nm for 1 = luteolin, 2 = kaempferol, 3 = apigenin, and 4 = rosmarinic acid.
Figure 2Cell viability of HUVECs treated with TMSE and TMCE in different concentrations compared to the control (untreated cells). HUVECs were exposed for 24 h to the TMSE and TMCE extracts in concentrations ranging between 0.8 and 3200 μg GAE/mL and between 1.175 and 4700 μg GAE/mL, respectively, compared to the control (untreated cells). Data are presented as a mean of OD ± SD, n = 3 for each sample. *** p < 0.001 vs. control.
Figure 3Malondialdehyde (MDA) levels in HUVECs after exposure to hyperglycemia and normoglycemia and after treatment with two different doses of TMCE and TMSE. Exposure to hyperglycemia (G) significantly increased MDA levels in cell lysates (p < 0.001) compared to the control while TMCE and TMSE in both concentrations reduced MDA formation (p < 0.001). Statistical significance of the difference between control groups and the ones treated with samples was evaluated with two-way ANOVA and Bonferroni post-hoc test. *** p < 0.001 vs. control cells and ### p < 0.001 vs. cells exposed to hyperglycemia.
Figure 4NF-ĸB, phosphorylated (p)NF-ĸB and HIF1-α expressions in HUVECs after exposure to hyperglycemia and normoglycemia and treatment with two doses of Thymus marschallianus extracts. Image analysis of WB bands was done by densitometry in upper panels (a) and results were normalized to GAPDH in lower panels (b–d). Exposure to hyperglycemia (G) increased the total NF-kB expression and its activation and enhanced the HIF1-α valued compared to the control cells. The treatment with the two extracts diminished the total NF-kB expression and reduced the active form of NF-kB, especially TMSE. Both extracts improved HIF1-α expression in hyperglycemic medium while TMCE increased the activation of NF-kB. The statistical significance between the treated cells and control group was assessed with two-way ANOVA followed by the Bonferroni post-hoc test. Each bar represents mean ± standard deviation (n = 3); ** p < 0.01 and *** p < 0.001 vs. control (untreated cells); # p < 0.05, ## p < 0.01, and ### p < 0.001 vs. cells exposed to hyperglycemia.
Figure 5HIF-1α and γ-H2AX expressions in HUVECs after exposure to hyperglycemia and normoglycemia and after treatment with T. marschallianus extracts. Image analysis of WB bands was done by densitometry in upper panels (a) and results were normalized to GAPDH in lower panels (b). The exposure to hyperglycemic medium induced DNA lesions while the two extracts exerted the protection on DNA damage. The statistical significance between the treated cells and control group was assessed with two-way ANOVA followed by the Bonferroni post-hoc test. Each bar represents mean ± standard deviation (n = 3); *** p < 0.001 vs. control (untreated cells); ### p < 0.001 vs. cells exposed to hyperglycemia.
The data obtained for the reference calibration curves.
| Standard | Concentration Range (mg/mL) | R2 | Detection Limit (mg/mL) | Quantification Limit (mg/mL) |
|---|---|---|---|---|
| Rosmarinic acid | 56–240 | 0.9946 | 3.5 | 7.1 |
| Luteolin | 40–300 | 0.9945 | 27.2 | 54.4 |
| Kaempferol | 40–300 | 0.9799 | 40.6 | 81.3 |
| Apigenin | 48–360 | 0.9990 | 15.6 | 26.1 |
| Rutoside | 300–500 | 0.9984 | 2.21 | 4.42 |
| Caffeic acid | 300–500 | 0.9994 | 124 | 186 |